Moxetumomab Pasudotox
Category: CancerMoxetumomab Pasudotox Overview
Moxetumomab pasudotox, sold under the brand name Lumoxiti, is an anti-CD22 immunotoxin for the treatment of adults with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.[2] Moxetumomab pasudotox is a CD22-directed cytotoxin and is the first of this type of treatment for adults with HCL.[2] The drug consists of the binding fragment (Fv) of an anti-CD22 an...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Moxetumomab_pasudotox
Recent Moxetumomab Pasudotox Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Moxetumomab Pasudotox
- Injection: 1mg/vial
Other drugs which contain Moxetumomab Pasudotox or a similar ingredient: (1 result)
- LUMOXITI Moxetumomab Pasudotox-tdfk